Cypress Point Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cypress Point Wealth Management's LLY Position: Q2 2026 in Review
Cypress Point Wealth Management increased its Eli Lilly (LLY) stake by 69% in Q2 2026, buying an estimated $265K and bringing the position to 637 shares worth $764K. The position accounts for 0.16% of the portfolio, ranked #64.
Cypress Point Wealth Management first reported a position in LLY in Q2 2021 and has held it in 7 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cypress Point Wealth Management held 637 shares of Eli Lilly worth $764K as of Q2 2026.
- Cypress Point Wealth Management bought 259 Eli Lilly shares in Q2 2026, an estimated $265K.
- Eli Lilly made up 0.16% of Cypress Point Wealth Management's portfolio in Q2 2026, its #64 holding.
- Cypress Point Wealth Management first reported a position in Eli Lilly in Q2 2021 and has held it in 7 quarters since.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cypress Point Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.